Efficacy of Atorvastatin in Chronic Subdural Haematoma

Phase 3 Unknown 690 enrolled Chinese University of Hong Kong

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This prospective, double-blind, randomized, placebo-controlled study aims to evaluate the efficacy and safety of atorvastatin in patients with chronic subdural haematoma. The degree of disability or dependence in daily activities, as well as surgical intervention or recurrence, of the treatment and control groups will be compared.

Timeline

Start: 2020-01-09
Primary completion: 2022-09-16
Completion: 2023-03-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atorvastatin	Small molecule	20 mg	Oral

Indications

No indication recorded.